472 314

Cited 0 times in

일산화질소 흡입요법에 반응하지 않는 중증 신생아 지속성 폐동맥 고혈압증 환자에서 분무식 iloprost (Ventavis(R))의 치료효과

Other Titles
 The Therapeutic Effect of Inhaled Iloprost in Newborn Infants with Severe Persistent Pulmonary Hypertension Refractory to Inhaled Nitric Oxide 
Authors
 Yoon Ki Han ; Soon Min Lee ; Chul Lee ; Kook In Park ; Min Soo Park ; Ran Namgung ; Jeong Eun Kim ; Ho Seon Eun 
Citation
 Korean Journal of Perinatology (대한주산의학회잡지), Vol.22(1) : 57~63, 2011 
Journal Title
 Korean Journal of Perinatology  (대한주산의학회잡지) 
ISSN
 1229-2605 
Issue Date
2011
Abstract
Inhaled iloprost, a stable carbacyline derivative of prostacyclin, has been used recently for the treatment of adults with pulmonary hypertension but only few reports are available about its use in neonatal critical care. We report therapeutic trial of inhaled iloprost in newborn infants with persistent pulmonary hypertension of the newborn (PPHN) who did not respond to inhaled nitric oxide (iNO). Inhaled iloprost (Ventavis(R), Bayer Shering Pharma, Germany) was effective in neonates with severe PPHN who showed inadequate response to iNO. We suggest that inhaled iloprost could be considered as an additional therapeutic option in PPHN refractory to iNO
URI
http://ir.ymlib.yonsei.ac.kr/handle/22282913/93938
Appears in Collections:
1. 연구논문 > 1. College of Medicine > Dept. of Pediatrics
Yonsei Authors
사서에게 알리기
  feedback
Files in This Item:
T201103124.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse